Showing 1 - 5 results of 5 for search 'P. Sportoletti°', query time: 0.02s Refine Results
  1. 1
    P664: GRADING QUALITY OF EVIDENCE AND STRENGTH OF RECOMMENDATIONS FOR THE TREATMENT OF RELAPSED/REFRACTORY CLL.

    P664: GRADING QUALITY OF EVIDENCE AND STRENGTH OF RECOMMENDATIONS FOR THE TREATMENT OF RELAPSED/REFRACTORY CLL. by S. Molica, C. Patti, P. Sportoletti, A. Chiarenza, A. M. Giordano, F. Chiurazzi, N. Di Renzo, P. Musto, F. Pane, F. Di Raimondo, L. Trentin, F. R. Mauro, D. Giannarelli

    Published 2022-06-01
    Get full text
    Article
  2. 2
    P458: TRANSCRIPTIONAL AND TRANSLATIONAL SIGNATURES OF TRIPLE MUTATED DNMT3AKO/FLT3ITD/NPM1C MICE SHOW ALTERED RNAS PROCESSING AND CELL CYCLE PROGRESSION

    P458: TRANSCRIPTIONAL AND TRANSLATIONAL SIGNATURES OF TRIPLE MUTATED DNMT3AKO/FLT3ITD/NPM1C MICE SHOW ALTERED RNAS PROCESSING AND CELL CYCLE PROGRESSION by A. Scialdone, D. Sorcini, A. Stella, V. Tini, A. Marra, C. Rompietti, F. De Falco, E. Dorillo, F. M. Adamo, E. C. Barcelos, R. Arcaleni, M. P. Martelli, P. Sportoletti°, B. Falini°;° co-last author

    Published 2022-06-01
    Get full text
    Article
  3. 3
    S139: BCOR DELETION SUSTAINS NOTCH1 SIGNALLING ACTIVATION TO ACCELERATE CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) PROGRESSION TOWARD RICHTER TRANSFORMATION IN MICE

    S139: BCOR DELETION SUSTAINS NOTCH1 SIGNALLING ACTIVATION TO ACCELERATE CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) PROGRESSION TOWARD RICHTER TRANSFORMATION IN MICE by C. Rompietti, D. Sorcini, F. De Falco, E. Dorillo, F. M. Adamo, E. C. Silva Barcelos, A. Stella, A. Scialdone, A. Esposito, R. Arcaleni, B. Bigerna, G. Martino, L. Moretti, M. G. Mameli, C. Geraci, L. Sandoletti, A. Cipiciani, E. Rosati, B. Falini, P. Sportoletti

    Published 2022-06-01
    Get full text
    Article
  4. 4
    P660: SEROLOGIC RESPONSE TO THE SECOND AND THIRD DOSE OF THE SARS-COV-2 VACCINE IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA: RESULTS OF A PROSPECTIVE, CENTRALIZED, MULTICENTER STUDY.

    P660: SEROLOGIC RESPONSE TO THE SECOND AND THIRD DOSE OF THE SARS-COV-2 VACCINE IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA: RESULTS OF A PROSPECTIVE, CENTRALIZED, MULTICENTER ST... by F. R. Mauro, D. Giannarelli, C. Galluzzo, A. Visentin, A. M. Frustaci, P. Sportoletti, C. Vitale, G. Reda, M. Gentile, L. Levato, R. Murru, D. Armiento, C. Ielo, R. Maglione, E. Crisanti, A. Cipiciani, V. Mattiello, V. Gianfelici, L. Barabino, R. Amici, M. Coscia, A. Tedeschi, L. Trentin, S. Baroncelli

    Published 2022-06-01
    Get full text
    Article
  5. 5
    P712: ASCIMINIB ITALIAN MANAGED ACCESS PROGRAM: EFFICACY PROFILE IN HEAVILY PRE-TREATED CML PATIENTS

    P712: ASCIMINIB ITALIAN MANAGED ACCESS PROGRAM: EFFICACY PROFILE IN HEAVILY PRE-TREATED CML PATIENTS by M. Breccia, A. V. Russo Rossi, B. Martino, E. Abruzzese, M. Annunziata, G. Binotto, A. Ermacora, C. Fava, L. Giaccone, V. Giai, A. P. Nardozza, P. Coco, A. Gozzini, L. Levato, A. Lucchesi, L. Luciano, M. Maria Cristina, G. Rege-Cambrin, M. Santoro, B. Scappini, A. R. Scortechini, P. Sportoletti, E. Trabacchi, F. Castagnetti

    Published 2022-06-01
    Get full text
    Article

Search Tools: